Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy

Journal of Alternative and Complementary Medicine

Volumn 17, Issue 6, 2011, Pages 505-512

  De Oliveira Campos, Maira Paschoin ^a,e   Riechelmann, Rachel ^a   Martins, Lourdes Conceição ^a   Hassan, Benjamin J ^b   Casa, Fernanda Branco Assunção ^c   Giglio, Auro Del ^a,d  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b UNIVERSITY OF MIAMI   (United States)

^c Pharmaceutical Biochemistry   (Brazil)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUARANA EXTRACT; PLACEBO;

ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; BRIEF FATIGUE INVENTORY; CANCER CHEMOTHERAPY; CHALDER FATIGUE SCALE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY ENDOCRINE SYMPTOMS; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE; GUARANA; HEART PALPITATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSOMNIA; MENOPAUSE; NAUSEA; PHASE 2 CLINICAL TRIAL; PITTSBURG SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SLEEP QUALITY;

EID: 79958219319     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2010.0571     Document Type: Article

References (39)

1. NCI. National Cancer Institute: Estimated Cancer Deaths for Selected Cancer Sites by State, US, 2009. Online document at: http://cancer.org/ downloads/STT/500809web.pdf Accessed December 3, 2009.
2. INCA BNCI. Brazilian National Institute of Cancer, Breast Cancer: Statistics on Incidence, Survival, and Screening. Online document at: http://inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/mama/cancer-mama Accessed December 3, 2009.
3. Jacobsen PB, Hann DM, Azzarello LM, et al. Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. J Pain Symptom Manage 1999;18:233-242. (Pubitemid 29469701)
4. Byar KL, Berger AM, Bakken SL, et al. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum 2006;33:E18-E26.
5. de Jong N, Courtens AM, Abu-Saad HH, et al. Fatigue in patients with breast cancer receiving adjuvant chemotherapy: A review of the literature. Cancer Nurs 2002;25:283-297; quiz 298-299. (Pubitemid 34815439)
6. Dagnelie PC, Pijls-Johannesma MC, Lambin P, et al. Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol 2007;18:940-944. (Pubitemid 47054093)
7. Madden J, Newton S. Why am I so tired all the time? Understanding cancer-related fatigue. Clin J Oncol Nurs 2006;10: 659-661.
8. Cheville AL. Cancer-related fatigue. Phys Med Rehabil Clin N Am 2009;20:405-416.
9. Williams SA, Schreier AM. The role of education in managing fatigue, anxiety, and sleep disorders in women undergoing chemotherapy for breast cancer. Appl Nurs Res 2005; 18:138-147. (Pubitemid 40994937)
10. Wang XS. Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs 2008;12:11-20.
11. Minton O, Richardson A, Sharpe M, et al. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 2008;100:1155-1166.
12. Smith N, Atroch AL. Guarana's journey from regional tonic to aphrodisiac and global energy drink. Evid Based Complement Alternat Med 2010;7:279-282.
13. Weckerle CS, Stutz MA, Baumann TW. Purine alkaloids in Paullinia. Phytochemistry 2003;64:735-742. (Pubitemid 37176407)
14. Espinola EB, Dias RF, Mattei R, et al. Pharmacological activity of Guarana (Paullinia cupana Mart.) in laboratory animals. J Ethnopharmacol 1997;55:223-229. (Pubitemid 27122310)
15. Mattei R, Dias RF, Espinola EB, et al. Guarana (Paullinia cupana): Toxic behavioral effects in laboratory animals and antioxidants activity in vitro. J Ethnopharmacol 1998;60: 111-116. (Pubitemid 28143720)
16. Haskell CF, Kennedy DO, Wesnes KA, et al. A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guarana in humans. J Psychopharmacol 2007;21:65-70. (Pubitemid 46012084)
17. da Costa Miranda V, Trufelli DC, Santos J, et al. Effectiveness of guarana (Paullinia cupana) for postradiation fatigue and depression: Results of a pilot double-blind randomized study. J Altern Complement Med 2009;15:431-433.
18. Miranda VC, Trufelli DC, Fêde ABS, et al. Guarana (Paullinia cupana) for chemotherapy-related fatigue. Einstein (São Paulo) 2008;6:195-199.
19. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer 1999;85:1186-1196. (Pubitemid 29115600)
20. Cho HJ, Costa E, Menezes PR, et al. Cross-cultural validation of the Chalder Fatigue Questionnaire in Brazilian primary care. J Psychosom Res 2007;62:301-304.
21. Morriss RK, Wearden AJ, Mullis R. Exploring the validity of the Chalder Fatigue scale in chronic fatigue syndrome. J Psychosom Res 1998;45:411-417. (Pubitemid 28499986)
22. Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997;13:63-74. (Pubitemid 27147321)
23. Cella D, Viswanathan HN, Hays RD, et al. Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy. Cancer 2008;113:1480-1488.
24. FACIT: The FACIT Measurement System: FACT-ES, for Patients with Endocrine Symptoms, Translations for FACTES. Online document at: http://facit.org/qview/ translations.aspx?scaleid38 Accessed: December 4, 2009.
25. Fallowfield LJ, Leaity SK, Howell A, et al. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 1999;55:189-199. (Pubitemid 29389581)
26. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. (Pubitemid 19144991)
27. Ceolim MF, Menna-Barreto L. Sleep/wake cycle and physical activity in healthy elderly people. Sleep Res Online 2000; 3:87-95.
28. Bertolazi ANFS, Hoff LS, Pedro VD, et al. Portuguese- Language Version of the Epworth Sleepiness Scale and Pittsburgh Sleep Quality Index: Validation for Use in Brazil. Online document at: http://lume.ufrgs.br/handle/10183/14041 Accessed December 4, 2008.
29. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370. (Pubitemid 13098606)
30. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res 2002;52:69-77. (Pubitemid 34192886)
31. Pais-Ribeiro J, Silva I, Ferreira T, et al. Validation study of a Portuguese version of the Hospital Anxiety and Depression Scale. Psychol Health Med 2007;12:225-235; quiz 235-237.
32. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13: 176-181. (Pubitemid 36962641)
33. Catedral CeC. Catedral Ciência e Consciência: Pharmaceutical Industry, Minas Gerais, Brazil. Online document at: http://laboratoriocatedral. com.br/Accessed November 22, 2008.
34. Bruera E, Valero V, Driver L, et al. Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073-2078. (Pubitemid 46622117)
35. Software G. GraphPad Prism: Basic Biostatistics, Curve Fitting and Scientific Graphing. Online document at: http://graphpad.com/prism/Accessed September 3, 2009.
36. Jones G. Caffeine and other sympathomimetic stimulants: Modes of action and effects on sports performance. Essays Biochem 2008;44:109-123.
37. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992;17:139-170.
38. Bohlius J, Schmidlin K, Brillant C, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials. Lancet 2009;373:1532-1542.
39. Alexander S, Minton O, Stone PC. Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. J Clin Oncol 2009;27:1197-1201.